1. Home
  2. LMAT vs RXRX Comparison

LMAT vs RXRX Comparison

Compare LMAT & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • RXRX
  • Stock Information
  • Founded
  • LMAT 1983
  • RXRX 2013
  • Country
  • LMAT United States
  • RXRX United States
  • Employees
  • LMAT N/A
  • RXRX N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LMAT Health Care
  • RXRX Health Care
  • Exchange
  • LMAT Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • LMAT 2.0B
  • RXRX 2.0B
  • IPO Year
  • LMAT 2006
  • RXRX 2021
  • Fundamental
  • Price
  • LMAT $94.88
  • RXRX $6.40
  • Analyst Decision
  • LMAT Buy
  • RXRX Buy
  • Analyst Count
  • LMAT 7
  • RXRX 6
  • Target Price
  • LMAT $92.83
  • RXRX $9.40
  • AVG Volume (30 Days)
  • LMAT 116.5K
  • RXRX 4.0M
  • Earning Date
  • LMAT 10-31-2024
  • RXRX 11-06-2024
  • Dividend Yield
  • LMAT 0.67%
  • RXRX N/A
  • EPS Growth
  • LMAT 49.21
  • RXRX N/A
  • EPS
  • LMAT 1.82
  • RXRX N/A
  • Revenue
  • LMAT $213,029,000.00
  • RXRX $49,635,000.00
  • Revenue This Year
  • LMAT $15.09
  • RXRX $57.90
  • Revenue Next Year
  • LMAT $9.19
  • RXRX $35.23
  • P/E Ratio
  • LMAT $52.11
  • RXRX N/A
  • Revenue Growth
  • LMAT 14.81
  • RXRX N/A
  • 52 Week Low
  • LMAT $47.33
  • RXRX $5.04
  • 52 Week High
  • LMAT $101.67
  • RXRX $15.74
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 62.88
  • RXRX 46.48
  • Support Level
  • LMAT $86.62
  • RXRX $6.32
  • Resistance Level
  • LMAT $90.82
  • RXRX $6.90
  • Average True Range (ATR)
  • LMAT 2.83
  • RXRX 0.33
  • MACD
  • LMAT 0.31
  • RXRX -0.01
  • Stochastic Oscillator
  • LMAT 60.01
  • RXRX 22.65

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: